• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-17(IL-17)通过衔接蛋白 TRAF5 和剪接调控因子 SF2(ASF)延长趋化因子 CXCL1 mRNA 的半衰期。

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

机构信息

Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

出版信息

Nat Immunol. 2011 Aug 7;12(9):853-60. doi: 10.1038/ni.2081.

DOI:10.1038/ni.2081
PMID:21822258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3597344/
Abstract

Interleukin 17 (IL-17) promotes the expression of chemokines and cytokines via the induction of gene transcription and post-transcriptional stabilization of mRNA. We show here that IL-17 enhanced the stability of chemokine CXCL1 mRNA and other mRNAs through a pathway that involved the adaptor Act1, the adaptors TRAF2 or TRAF5 and the splicing factor SF2 (also known as alternative splicing factor (ASF)). TRAF2 and TRAF5 were necessary for IL-17 to signal the stabilization of CXCL1 mRNA. Furthermore, IL-17 promoted the formation of complexes of TRAF5-TRAF2, Act1 and SF2 (ASF). Overexpression of SF2 (ASF) shortened the half-life of CXCL1 mRNA, whereas depletion of SF2 (ASF) prolonged it. SF2 (ASF) bound chemokine mRNA in unstimulated cells, whereas the SF2 (ASF)-mRNA interaction was much lower after stimulation with IL-17. Our findings define an IL-17-induced signaling pathway that links to the stabilization of selected mRNA species through Act1, TRAF2-TRAF5 and the RNA-binding protein SF2 (ASF).

摘要

白细胞介素 17(IL-17)通过诱导基因转录和 mRNA 的转录后稳定来促进趋化因子和细胞因子的表达。我们在这里表明,IL-17 通过涉及衔接蛋白 Act1、衔接蛋白 TRAF2 或 TRAF5 和剪接因子 SF2(也称为选择性剪接因子(ASF))的途径增强趋化因子 CXCL1 mRNA 和其他 mRNA 的稳定性。TRAF2 和 TRAF5 对于 IL-17 信号转导 CXCL1 mRNA 的稳定是必需的。此外,IL-17 促进了 TRAF5-TRAF2、Act1 和 SF2(ASF)的复合物的形成。SF2(ASF)的过表达缩短了 CXCL1 mRNA 的半衰期,而 SF2(ASF)的耗竭则延长了半衰期。SF2(ASF)在未刺激的细胞中结合趋化因子 mRNA,而在受到 IL-17 刺激后,SF2(ASF)-mRNA 相互作用要低得多。我们的研究结果定义了一种 IL-17 诱导的信号通路,该通路通过 Act1、TRAF2-TRAF5 和 RNA 结合蛋白 SF2(ASF)与选定的 mRNA 种类的稳定化相关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/371721e37b9b/nihms425721f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/4557327c44a6/nihms425721f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/19f02d81492e/nihms425721f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/2b59a5130571/nihms425721f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/5ebd310bcd0b/nihms425721f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/168d3b7db177/nihms425721f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/b344b09f61ff/nihms425721f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/371721e37b9b/nihms425721f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/4557327c44a6/nihms425721f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/19f02d81492e/nihms425721f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/2b59a5130571/nihms425721f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/5ebd310bcd0b/nihms425721f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/168d3b7db177/nihms425721f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/b344b09f61ff/nihms425721f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/3597344/371721e37b9b/nihms425721f7.jpg

相似文献

1
Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).白细胞介素-17(IL-17)通过衔接蛋白 TRAF5 和剪接调控因子 SF2(ASF)延长趋化因子 CXCL1 mRNA 的半衰期。
Nat Immunol. 2011 Aug 7;12(9):853-60. doi: 10.1038/ni.2081.
2
The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.诱导型激酶 IKKi 是白细胞介素-17(IL-17)依赖性信号转导所必需的,该信号转导与嗜中性粒细胞增多和肺部炎症有关。
Nat Immunol. 2011 Aug 7;12(9):844-52. doi: 10.1038/ni.2080.
3
IL-17R signaling: new players get in on the Act1.白细胞介素-17受体信号传导:新角色登场
Nat Immunol. 2011 Aug 18;12(9):813-5. doi: 10.1038/ni.2093.
4
Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25.泛素特异性蛋白酶 USP25 对 IL-17 介导的信号转导和炎症的负调控。
Nat Immunol. 2012 Nov;13(11):1110-7. doi: 10.1038/ni.2427. Epub 2012 Oct 7.
5
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.hnRNP A1/A2 和 SF2/ASF 调节干扰素调节因子-3 的可变剪接,影响人非小细胞肺癌细胞的免疫调节功能。
PLoS One. 2013 Apr 29;8(4):e62729. doi: 10.1371/journal.pone.0062729. Print 2013.
6
Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.PKCI-1相关mRNA的稳定性受剪接因子ASF/SF2调控:SR蛋白的一种新功能。
Genes Dev. 2002 Mar 1;16(5):594-607. doi: 10.1101/gad.939502.
7
Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene.Sam68 通过选择性剪接激活的无意义介导的 mRNA 降解调控 EMT 过程,从而抑制 SF2/ASF 原癌基因。
J Cell Biol. 2010 Oct 4;191(1):87-99. doi: 10.1083/jcb.201001073. Epub 2010 Sep 27.
8
HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization.HuR 对于白细胞介素-17 诱导的 Act1 介导的 CXCL1 和 CXCL5 mRNA 稳定是必需的。
J Immunol. 2013 Jul 15;191(2):640-9. doi: 10.4049/jimmunol.1203315. Epub 2013 Jun 14.
9
IL-17 enhances chemokine gene expression through mRNA stabilization.白细胞介素-17通过信使核糖核酸稳定性增强趋化因子基因表达。
J Immunol. 2007 Sep 15;179(6):4135-41. doi: 10.4049/jimmunol.179.6.4135.
10
SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.SF2/ASF 自身调控涉及转录后和翻译水平的多层级控制。
Nat Struct Mol Biol. 2010 Mar;17(3):306-12. doi: 10.1038/nsmb.1750. Epub 2010 Feb 7.

引用本文的文献

1
Chemokines: humble yet mighty players in the tumour microenvironment.趋化因子:肿瘤微环境中虽不起眼却强大的参与者。
Front Immunol. 2025 Aug 7;16:1601756. doi: 10.3389/fimmu.2025.1601756. eCollection 2025.
2
Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation.γ疱疹病毒感染会刺激促进肺癌的炎症反应。
Pathogens. 2024 Aug 31;13(9):747. doi: 10.3390/pathogens13090747.
3
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease.细胞因子 IL-17 和 IL-22 在调节代谢相关脂肪性肝病中的作用。

本文引用的文献

1
The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression.剪接因子 ASF/SF2 与 TIA-1 相关/TIA-1 内含的核糖核蛋白复合物相关联,并有助于基因表达的转录后抑制。
FEBS J. 2010 Jun;277(11):2496-514. doi: 10.1111/j.1742-4658.2010.07664.x. Epub 2010 Apr 30.
2
Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression.细胞因子基因表达的转录后调控中的多样性。
Cytokine. 2010 Oct-Nov;52(1-2):116-22. doi: 10.1016/j.cyto.2010.04.003. Epub 2010 Apr 28.
3
Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.
Front Immunol. 2024 Aug 2;15:1437046. doi: 10.3389/fimmu.2024.1437046. eCollection 2024.
4
The RNA binding protein Arid5a drives IL-17-dependent autoantibody-induced glomerulonephritis.RNA 结合蛋白 Arid5a 驱动白细胞介素 17 依赖性自身抗体诱导的肾小球肾炎。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20240656. Epub 2024 Jul 26.
5
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis.Act1 通过调节抗氧化 RNA 代谢和氧化还原平衡来驱动化疗耐药性。
J Exp Med. 2024 Jul 1;221(7). doi: 10.1084/jem.20231442. Epub 2024 Jun 11.
6
An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection.增强的 IL17 和抑制的 I 型干扰素鼻上皮细胞状态是 COVID-19 合并真菌感染的严重特征。
Microbiol Spectr. 2024 Jun 4;12(6):e0351623. doi: 10.1128/spectrum.03516-23. Epub 2024 Apr 30.
7
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.长链非编码RNA MALAT-1:癌症进展、转移、免疫及治疗抗性中的多功能调节因子
Noncoding RNA Res. 2024 Feb 1;9(2):388-406. doi: 10.1016/j.ncrna.2024.01.015. eCollection 2024 Jun.
8
The IL-17 family in diseases: from bench to bedside.IL-17 家族与疾病:从基础到临床。
Signal Transduct Target Ther. 2023 Oct 11;8(1):402. doi: 10.1038/s41392-023-01620-3.
9
IL-17: Balancing Protective Immunity and Pathogenesis.IL-17:平衡保护性免疫和发病机制。
J Immunol Res. 2023 Aug 12;2023:3360310. doi: 10.1155/2023/3360310. eCollection 2023.
10
New insights into the function of Interleukin-25 in disease pathogenesis.白细胞介素-25在疾病发病机制中的功能新见解。
Biomark Res. 2023 Apr 1;11(1):36. doi: 10.1186/s40364-023-00474-9.
星形胶质细胞特异性敲除白细胞介素 17 诱导的 Act1 介导的信号通路可改善自身免疫性脑脊髓炎。
Immunity. 2010 Mar 26;32(3):414-25. doi: 10.1016/j.immuni.2010.03.004. Epub 2010 Mar 18.
4
IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence.IL-17 通过非 AUUUA/三肽重复蛋白依赖序列调节 CXCL1 mRNA 的稳定性。
J Immunol. 2010 Feb 1;184(3):1484-91. doi: 10.4049/jimmunol.0902423. Epub 2009 Dec 30.
5
Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.Act1,一种参与白细胞介素-17信号传导的U-box E3泛素连接酶。
Sci Signal. 2009 Oct 13;2(92):ra63. doi: 10.1126/scisignal.2000382.
6
Structural basis for the lack of E2 interaction in the RING domain of TRAF2.肿瘤坏死因子受体相关因子2(TRAF2)的环状结构域中缺乏E2相互作用的结构基础。
Biochemistry. 2009 Nov 10;48(44):10558-67. doi: 10.1021/bi901462e.
7
Structure and signalling in the IL-17 receptor family.白细胞介素-17受体家族的结构与信号传导
Nat Rev Immunol. 2009 Aug;9(8):556-67. doi: 10.1038/nri2586. Epub 2009 Jul 3.
8
IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6.IL-17信号传导促进mRNA稳定并不需要肿瘤坏死因子受体相关因子6。
J Immunol. 2009 Feb 1;182(3):1660-6. doi: 10.4049/jimmunol.182.3.1660.
9
IL-17 and Th17 Cells.白细胞介素-17与辅助性T细胞17
Annu Rev Immunol. 2009;27:485-517. doi: 10.1146/annurev.immunol.021908.132710.
10
The SR protein family of splicing factors: master regulators of gene expression.剪接因子的SR蛋白家族:基因表达的主要调控因子。
Biochem J. 2009 Jan 1;417(1):15-27. doi: 10.1042/BJ20081501.